Bifogade filer
Kurs & Likviditet
Prenumeration
Kalender
2025-02-06 | Bokslutskommuniké 2024 |
2024-10-24 | Kvartalsrapport 2024-Q3 |
2024-07-19 | Kvartalsrapport 2024-Q2 |
2024-05-06 | X-dag ordinarie utdelning CEVI 2.25 SEK |
2024-05-03 | Årsstämma 2024 |
2024-04-25 | Kvartalsrapport 2024-Q1 |
2024-02-07 | Bokslutskommuniké 2023 |
2023-10-25 | Kvartalsrapport 2023-Q3 |
2023-07-20 | Kvartalsrapport 2023-Q2 |
2023-05-08 | X-dag ordinarie utdelning CEVI 2.25 SEK |
2023-05-05 | Årsstämma 2023 |
2023-05-04 | Kvartalsrapport 2023-Q1 |
2023-02-07 | Bokslutskommuniké 2022 |
2022-10-26 | Kvartalsrapport 2022-Q3 |
2022-07-20 | Kvartalsrapport 2022-Q2 |
2022-05-12 | X-dag ordinarie utdelning CEVI 2.00 SEK |
2022-05-11 | Årsstämma 2022 |
2022-05-10 | Kvartalsrapport 2022-Q1 |
2022-02-04 | Bokslutskommuniké 2021 |
2021-10-22 | Kvartalsrapport 2021-Q3 |
2021-07-20 | Kvartalsrapport 2021-Q2 |
2021-04-30 | X-dag ordinarie utdelning CEVI 0.75 SEK |
2021-04-29 | Årsstämma 2021 |
2021-04-28 | Kvartalsrapport 2021-Q1 |
2021-02-04 | Bokslutskommuniké 2020 |
2020-10-23 | Kvartalsrapport 2020-Q3 |
2020-07-16 | Kvartalsrapport 2020-Q2 |
2020-06-17 | X-dag ordinarie utdelning CEVI 0.00 SEK |
2020-06-16 | Årsstämma 2020 |
2020-04-22 | Kvartalsrapport 2020-Q1 |
2020-02-05 | Bokslutskommuniké 2019 |
2019-10-23 | Kvartalsrapport 2019-Q3 |
2019-07-16 | Kvartalsrapport 2019-Q2 |
2019-05-09 | X-dag ordinarie utdelning CEVI 1.50 SEK |
2019-05-08 | Årsstämma 2019 |
2019-05-07 | Kvartalsrapport 2019-Q1 |
2019-02-07 | Bokslutskommuniké 2018 |
2018-10-23 | Kvartalsrapport 2018-Q3 |
2018-07-19 | Kvartalsrapport 2018-Q2 |
2018-05-07 | X-dag ordinarie utdelning CEVI 1.50 SEK |
2018-05-04 | Årsstämma 2018 |
2018-05-03 | Kvartalsrapport 2018-Q1 |
2018-02-09 | Bokslutskommuniké 2017 |
2017-10-25 | Kvartalsrapport 2017-Q3 |
2017-07-18 | Kvartalsrapport 2017-Q2 |
2017-05-08 | X-dag ordinarie utdelning CEVI 1.50 SEK |
2017-05-05 | Årsstämma 2017 |
2017-05-04 | Kvartalsrapport 2017-Q1 |
2017-02-07 | Bokslutskommuniké 2016 |
2016-10-27 | Kvartalsrapport 2016-Q3 |
2016-07-15 | Kvartalsrapport 2016-Q2 |
2016-05-06 | X-dag ordinarie utdelning CEVI 1.50 SEK |
2016-05-04 | Årsstämma 2016 |
2016-05-03 | Kvartalsrapport 2016-Q1 |
2016-02-12 | Bokslutskommuniké 2015 |
2015-11-09 | Kvartalsrapport 2015-Q3 |
2015-07-17 | Kvartalsrapport 2015-Q2 |
2015-05-07 | X-dag ordinarie utdelning CEVI 1.00 SEK |
2015-05-06 | Årsstämma 2015 |
2015-05-05 | Kvartalsrapport 2015-Q1 |
2015-02-12 | Bokslutskommuniké 2014 |
2014-11-05 | Kvartalsrapport 2014-Q3 |
2014-07-18 | Kvartalsrapport 2014-Q2 |
2014-05-08 | X-dag ordinarie utdelning CEVI 0.50 SEK |
2014-05-07 | Årsstämma 2014 |
2014-05-06 | Kvartalsrapport 2014-Q1 |
2014-02-13 | Bokslutskommuniké 2013 |
2013-10-24 | Kvartalsrapport 2013-Q3 |
2013-07-17 | Kvartalsrapport 2013-Q2 |
2013-04-25 | X-dag ordinarie utdelning CEVI 0.40 SEK |
2013-04-24 | Årsstämma 2013 |
2013-04-24 | Kvartalsrapport 2013-Q1 |
2013-02-14 | Bokslutskommuniké 2012 |
2012-10-26 | Kvartalsrapport 2012-Q3 |
2012-07-18 | Kvartalsrapport 2012-Q2 |
2012-05-24 | Kapitalmarknadsdag 2012 |
2012-05-03 | X-dag ordinarie utdelning CEVI 0.40 SEK |
2012-05-02 | Årsstämma 2012 |
2012-04-25 | Kvartalsrapport 2012-Q1 |
2012-02-14 | Bokslutskommuniké 2011 |
2011-10-25 | Kvartalsrapport 2011-Q3 |
2011-07-15 | Kvartalsrapport 2011-Q2 |
2011-04-27 | X-dag ordinarie utdelning CEVI 0.00 SEK |
2011-04-26 | Årsstämma 2011 |
2011-04-20 | Kvartalsrapport 2011-Q1 |
2011-02-15 | Bokslutskommuniké 2010 |
2010-10-27 | Kvartalsrapport 2010-Q3 |
2010-07-16 | Kvartalsrapport 2010-Q2 |
2010-04-30 | X-dag ordinarie utdelning CEVI 0.00 SEK |
2010-04-29 | Kvartalsrapport 2010-Q1 |
2010-02-12 | Bokslutskommuniké 2009 |
2009-10-23 | Kvartalsrapport 2009-Q3 |
2009-07-15 | Kvartalsrapport 2009-Q2 |
2009-04-27 | Årsstämma 1 |
2009-04-27 | Kvartalsrapport 2009-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
CellaVision AB (publ) will publish the Interim report for the third quarter, on October 26, 2022 at 7:20 CEST. The report will be available at ir.cellavision.com
In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CEST where Simon Østergaard, President & CEO, will present and comment the report.
The presentation will be in English via a conference call or audio webcast:
https://ir.financialhearings.com/cellavision-q3-2022
Dial in details:
SE: +46 8 51 9993 83
UK: +44 33 33 009 268
US: +1 64 67 224 902
No pre-registration is required. Please dial in 5-10 minutes prior to the scheduled start time to facilitate a timely start.
Contact
Adele Horn
Corporate Communications & Investor Relations
Direct: + 46 46 460 26 04
Mobile: + 46 72 206 50 88
www.cellavision.com
adele.horn@cellavision.com
About Us
CellaVision is a global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products replace manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in sample preparation, image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the parent company in Lund and by the company´s 17 local market support organizations covering more than 40 countries. In 2021, sales were SEK 566 million and the company's growth target is 15% per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Mid Cap list. Read more at www.cellavision.com